Concepedia

Publication | Closed Access

Results of a Randomized Phase III Trial of Mirabegron in Patients with Overactive Bladder

DOI

364

Citations

18

References

2012

Year

Victor W. Νitti, Stephen M. Auerbach, Nancy Martin, Alaina Calhoun, Misun Lee, Sender Herschorn
The Journal of Urology

Abstract

Once daily mirabegron in a 50 or 100 mg dose is an effective treatment for overactive bladder symptoms with a low occurrence of side effects.

References

YearCitations

Page 1